Apogee Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
Apogee Therapeutics, Inc. (APGE) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $94.30 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-03-02
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $94.30M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $28.50M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $6.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2025-12-31 | $94.30M 10-K · filed 2026-03-02 |
| 2024-12-31 | $28.50M 10-K · filed 2026-03-02 |
| 2023-12-31 | $6.50M 10-K · filed 2025-03-03 |